Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Aliment Pharmacol Ther. 2012 Jan 13;35(5):562–567. doi: 10.1111/j.1365-2036.2011.04986.x

Table 2.

Infusion history of patients with UC on maintenance infliximab

Therapy History N=50
Mean months on IFX (SEM) 14 (4)
Mean number of infusions 11 (1)
Mean months of follow-up (SEM) 38 (4)
Infusion reactions 9%
IFX stopped due to ADRs 3%

mo, months; ADRs, adverse drug reactions